Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study)

University of Nebraska

Status: Withdrawn

Conditions: Head and Neck Cancer

Treatments: Behavioral: Intervention group

Study type: Interventional

Funder types: Other

Identifiers

NCT00756795

0053-08-FB

Details and patient eligibility

About

Generally, patients who have undergone treatments for Head Neck Cancer have a decreased quality of life and experience depression and fatigue. Regular physical activity improves emotional well-being, increases immunological response, improves wound healing, lessens fatigue and improves general functionality and quality of life.

This study will determine effectiveness of the 12-week exercise intervention program, determine if physically active patients differ in quality of life, depression and fatigue during the course of the study, and determine if the change in physical activity levels is related to changes in immune responses.

Full description

The general hypothesis of this research is that patients who have undergone treatments for Head Neck Cancer have a decreased quality of life and experience depression and fatigue. Increasing and sustaining physical activity of these patients will improve their emotional well-beings, increase their immunological response, improve wound healing, lessen fatigue and improve their general functionality and quality of life.

The purposes of this study are to: (1) determine the effectiveness of the 12-week exercise intervention program in increasing physical activity in head and neck cancer patients; (2) determine if physically active patients differ in quality of life, depression and fatigue during the course of the study; and (3) determine if the change in physical activity levels is related to changes in the immune responses in human.

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients 19 years of age or above (Nebraska legal age).
2. Patients diagnosed with HNC who are seen at the University of Nebraska Medical Center.
3. Patients who have undergone chemotherapy, radiation and/or surgery for their cancer.
4. Patients who have completed their cancer treatment at least 3 months prior.
5. Patients who have consented to participate in this study with approval by their physicians.
6. Patients who have no significant mental impairment.

Exclusion criteria

1. Patients who are on enteral feeding.
2. Patients who are not able to walk or whose surgeons report that walking is not advisable.
3. Patients diagnosed with Lymphoma, Thyroid cancer or Melanoma.
4. Patients who are on antidepressant medications.
5. Patients who are unwilling to return to the clinic at the end of the study - after 12 weeks of intervention.
6. Patients participating in another research study involving a therapeutic intervention.
7. Patients with chronic medical and orthopedic conditions that would preclude physical activity (e.g., congestive heart failure, recent knee or hip replacements).
8. Patients who are at 18 months or more after the start of cancer treatment.

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Attention Control

Experimental group

Description:

5ml of blood will be collected from each blood draw at baseline and post-intervention to assay for Interleukin-6 level. Patient will be taught how to keep the Activity diary to record walking and physical activities. Structured Interview will be conducted at baseline and post-intervention. All patients will receive 3 reminder phone calls during the first week of study and 10 minutes social visits in the following weeks by study coordinator on a weekly basis

Treatment:

Behavioral: Intervention group